Open access · CC-BY
via OpenAlex
CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease
Yuanyuan Li, Mengyue Niu, Aonan Zhao, Wenyan Kang, Zhichun Chen, Ningdi Luo, Liche Zhou, Xiongwei Zhu, Liming Lu, Jun Liu
Journal of Neuroinflammation · 2019 · ▲ 75 citations
Abstract
BACKGROUND: The mechanisms underlying the pathogenesis and progression of Parkinson's disease (PD) remain elusive, but recent opinions and perspectives have focused on whether the inflammation process induced by microglia contributes to α-synuclein-mediated toxicity. Migration of microglia to the substantia nigra (SN) could precede neurodegeneration in A53T mice. We hypothesized that CXCL12 could be a mediator in the α-synuclein-induced migration of microglia. METHODS: After establishing appropriate animal and cell culture models, we explored the relationship between α-synuclein and CXCL12 in A53T mice, primary microglia, and BV-2 cell lines. We also explored the mechanisms of these interactions and the signaling processes involved in neuroinflammation. RESULTS: We confirmed the positive correlation between α-synuclein and CXCL12 in the postmortem brain tissue of PD patients and the upregulated CXCR4 expression in SN microglia of A53T mice. In addition, as expected, α-synuclein increased the production of CXCL12 in microglia via TLR4/IκB-α/NF-κB signaling. Importantly, CXCL12/CXCR4/FAK/Src/Rac1 signaling was shown to be involved in α-synuclein-induced microglial accumulation. CONCLUSIONS: Our study suggests that CXCL12 could be a novel target for the prevention of α-synuclein-triggered ongoing microglial responses. Blocking CXCL12/CXCR4 may be a potential therapeutic approach for PD progression.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s12974-019-1646-6
- Canonical
- link ↗
- Fetched
- 2026-11-06 MST
Cite this
APA
Li, Y., Niu, M., Zhao, A., Kang, W., Chen, Z., Luo, N., Zhou, L., Zhu, X., Lu, L., & Liu, J. (2019). CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease. <em>Journal of Neuroinflammation</em>. https://doi.org/10.1186/s12974-019-1646-6
Vancouver
Li Y, Niu M, Zhao A, Kang W, Chen Z, Luo N, et al. CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease. Journal of Neuroinflammation. 2019. doi:10.1186/s12974-019-1646-6.
BibTeX
@article{yuanyuan2019CXCLis,
title = {CXCL12 is involved in α-synuclein-triggered neuroinflammation of Parkinson’s disease},
author = {Yuanyuan Li and Mengyue Niu and Aonan Zhao and Wenyan Kang and Zhichun Chen and Ningdi Luo and Liche Zhou and Xiongwei Zhu and Liming Lu and Jun Liu},
journal = {Journal of Neuroinflammation},
year = {2019},
doi = {10.1186/s12974-019-1646-6},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
biorxiv 2024
Preprint · CC-BY
Impaired 26S proteasome causes leaning and memory deficiency and induces neuroinflammation mediated by NF-kappaB in mice
npj Aging 2026
Open access · CC-BY
Early mitophagy activation by Urolithin A prevents, but late activation does not reverse, age-related cognitive impairment
npj aging 2026
Open access · OA
Early mitophagy activation by Urolithin A prevents, but late activation does not reverse, age-related cognitive impairment.
Journal of Clinical Medicine 2024
Open access · CC-BY
Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects
Brain Research Reviews 2005
Citation only
Microglia and neuroprotection: implications for Alzheimer's disease
International Journal of Molecular Sciences 2024
Open access · CC-BY